Zinaida Tigay

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis et al. · New England Journal of Medicine · 2022 · 352 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures

Helen Cox, Stobdan Kalon, Sholpan Allamuratova et al. · PLoS ONE · 2007 · 107 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial

Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis et al. · The Lancet Respiratory Medicine · 2023 · 96 citations · Full text

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +12

Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study

Tatiana Belkina, Doniyor S Khojiev, Mirzagaleb Tillyashaykhov et al. · BMC Infectious Diseases · 2014 · 53 citations · Full text

Public Health, Infectious Disease Control, Internal Medicine +16

Risk Factors Associated with Default from Multi- and Extensively Drug-Resistant Tuberculosis Treatment, Uzbekistan: A Retrospective Cohort Analysis

Maeve K. Lalor, Jane Greig, Sholpan Allamuratova et al. · PLoS ONE · 2013 · 39 citations · Full text

Public Health, Infectious Disease Control, Clinical Pharmacology +14